15 mg/ml tirzepatide Zepbound (Tirzepatide) 15mg/0.5mL Pre-Filled Pens Injection – Apothera Tirzepatide 15mg - Clearlake Labs
Description
Orforglipron an oral GLP-1 drug in development, is being studied for weight loss and diabetes
The South Africa Diabetes Drugs Market Size is Anticipated to Reach USD 420.72 Million by 2033, Growing at a CAGR of 2.37% from 2023 to 2033.Clicks Group (ZAF)
Kailera will launch a global Phase 2 study of ribupatide this year, while Hengrui will push the asset into Phase 3 in China.
Clinical Frameworks: Defining Obesity Beyond Body Mass Index (BMI) An important milestone of 2025 was the publication of The Lancet Diabetes & Endocrinology Commission on the Definition and Diagnostic Criteria of Clinical Obesity
R&D expenses rose to 614 million, representing 5.8% of revenue
Weight management is evolving
